BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)
| 37.62 Delayed Data As of 3:59pm ET |  +3.39 / +9.90%Today’s Change | 5.20 Today|||52-Week Range 62.00 | +304.95% Year-to-Date |
Latest BVXV News | Press Releases
No recent news for BiondVax Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 34.23 |
| Today’s open | 34.90 |
| Day’s range | 34.90 - 40.10 |
| Volume | 3,841 |
| Average volume (3 months) | 103,193 |
| Market cap | $390.5M |
Data as of 3:59pm ET, 08/03/2020
Growth & Valuation
| Earnings growth (last year) | -0.51% |
| Earnings growth (this year) | +81.82% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HEXOHexo Corp | +0.05 | +6.73% |
| CDXCChromadex Corp | +0.10 | +1.98% |
| OGIOrganiGram Holdings ... | +0.04 | +3.66% |
| NATRNatures Sunshine Pro... | +0.91 | +9.57% |
Data as of 3:59pm ET, 08/03/2020
Financials
| Next reporting date | August 26, 2020 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$30.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
